Articles about 'MRC Laboratory of Molecular Biology'

Nine Cambridge researchers are among the latest recipients of highly competitive and prestigious European Research Council (ERC) Starting Grants.

Dr Elizabeth Barsotti is on a mission to map brains from across the animal kingdom. Her work is straight out of science fiction.

Seven outstanding Cambridge researchers have been elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.

Researchers have built the first ever map showing every single neuron and how they’re wired together in the brain of the fruit fly larva.

Scientists may have solved the question of why Ashkenazi Jews are significantly more susceptible to a rare genetic disorder known as Gaucher disease – and the answer may help settle the debate about whether they are less susceptible to tuberculosis (TB).

When Madeline Lancaster’s attempt to grow neural stem cells ‘failed’ she had no idea that the floating balls of cells she saw in her petri dish were in fact miniature brain tissues. They would revolutionise our ability to study the early stages of brain development and take us closer to answering: what makes us human?

Professor Dame Jocelyn Bell Burnell has become only the second woman to be awarded the Royal Society’s prestigious Copley Medal, the world’s oldest scientific prize.

Eight Cambridge researchers - six from the University of Cambridge and two from the MRC Laboratory of Molecular Biology - are among the 63 scientists from around the world elected this year as Members and Associate Members of the European Molecular Biology Organisation (EMBO).

We spoke with Cambridge’s most recent Nobel Laureate about decades of research, spin-outs, pharma giants and the booming life sciences cluster in Greater Cambridge.

Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry, along with Frances Arnold and George Smith, for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals.